Aptar Q3: $58M Russia Write-Off Halves Net Income; Q4 EPS Guided $1.39-$1.47
ATR sits 37% above its 52-week low of $103.227 on light trading volume (0.2× avg).
Summary
Aptar's Q3 sales rose 6% to $1.02 billion, but a $58.0 million Russia deconsolidation charge and a 45.6% tax rate cut net income to $32.6 million; Q4 adjusted EPS is guided to $1.39-$1.47.
Key Events · Earnings and Guidance · ATR
-
Russia Subsidiary Deconsolidated
A September 21, 2026 presidential decree placed OOO Aptar Vladimir under external administration; Aptar recorded a $58.0 million loss on deconsolidation and lost access to $30.0 million of cash.
-
Q3 Net Income Halved
Net income attributable to Aptar fell to $32.6 million ($0.51 diluted) from $127.9 million ($1.92), with the effective tax rate at 45.6% versus 17.1% a year ago.
-
Sales Up, Margins Compressed
Net sales rose 6% to $1,019.1 million with 5% core growth, but operating income slipped to $135.0 million (13.3% margin) from $136.9 million (14.3%) as cost of sales reached 63.4% of sales.
-
Q4 Guidance and Dividend Raised
Q4 2026 adjusted EPS is guided to $1.39-$1.47 on a 17.5%-19.5% tax rate and 1.12 EUR/USD; the quarterly dividend rises to $0.50 per share payable December 3, 2026.
Analysis · ATR · Industrial Applications And Services
Top-line growth of 6% to $1.02 billion was overshadowed by a $58.0 million non-cash loss on deconsolidating the Russian subsidiary, placed under external administration by a September 21 presidential decree; $30.0 million of cash held there is now unreachable. Because the charge is non-deductible, the effective tax rate jumped to 45.6% and net income fell to $32.6 million ($0.51 diluted) from $127.9 million a year ago, which itself included a $26.5 million one-time gain. Operations also softened: operating income slipped to $135.0 million as cost of sales rose to 63.4% of sales on an unfavorable Pharma mix and input costs passed through at no margin. Management guided Q4 adjusted EPS to $1.39-$1.47 and raised the quarterly dividend to $0.50.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ATR was trading at $141.38 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $9B. The 52-week trading range was $103.23 to $146.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.